Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Thorne Healthtech, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/13/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/05/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/05/2023 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/27/2023 |
8-K
| Other Events Interactive Data |
| 08/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results|
Docs:
|
"Thorne HealthTech Reports Second Quarter 2023 Results Record Net Sales With Growth of 33.1%; Raises Full-Year Guidance Midpoints for Net Sales and Gross Margin NEW YORK, August 8, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. , a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter Highlights: • Net sales grew 33.1% year-over-year to $72.7 million, with direct-to-consumer sales growth of 39.3% • Gross profit grew 35.7% year-over-year to $40.6 million; gross profit as a % of net sales increased year-over-year to 55.9%. • Net income attributable to Thorne HealthTech, Inc. of $4.4 million; adjusted EBITDA1 of $12.5 mi..." |
|
| 07/03/2023 |
4
| JACOBSON PAUL F (CEO) has filed a Form 4 on Thorne Healthtech, Inc.|
Txns:
| Gifted 220,377 shares
@ $0 |
|
| 06/01/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results|
Docs:
|
"Thorne HealthTech Reports First Quarter 2023 Results Net Sales Growth of 20.7%; Reaffirms Full-Year 2023 Guidance NEW YORK, May 11, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. , a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the first quarter ended March 31, 2023. First Quarter Highlights: • Net sales grew 20.7% year-over-year to $65.2 million, with direct-to-consumer sales growth of 41.0% • Gross profit grew 16.3% year-over-year to $34.3 million; gross profit as a % of net sales decreased year-over-year to 52.5% • Net loss attributable to Thorne HealthTech, Inc. of $ million; adjusted EBITDA1 of $6.1 million • Diluted earnings per share of $; adjusted..." |
|
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/03/2023 |
8-K/A
| Results of Operations and Financial Condition Interactive Data |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial State...|
Docs:
|
"STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT, dated as of January 31, 2023 , is by and between PreCon Acquisition LLC, a Delaware limited liability company , Thorne HealthTech, Inc., a South Carolina corporation , and for purposes of Sections 1.6 and 5.5 and Article VI, Eigenlyfe LLC, a Delaware limited liability company . Each of Seller and Purchaser are referred to as a “Party” and are collectively referred to as the “Parties.” WITNESSETH: WHEREAS, Seller owns all of the issued and outstanding shares of capital stock of PreCon Health, Inc., a Delaware corporation ; WHEREAS, Purchaser desires to own, indirectly, the assets of the Company, including: the SynaQuell and SynaQuell + nutritional supplement products ; all intellectual property presently own...",
"THORNE HEALTHTECH ACQUIRES PRECON HEALTH Acquisition of PreCon strengthens brain health portfolio and provides access to world-class scientific advisory board NEW YORK – Feb. 3, 2023 – Thorne HealthTech, Inc. (“Thorne” or “Thorne HealthTech”" |
|
| 01/04/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/05/2022 |
4
| Conley Bryan K. (CFO) has filed a Form 4 on Thorne Healthtech, Inc.|
Txns:
| Paid exercise price by delivering 7,838 shares
@ $4.89, valued at
$38.3k
|
|
| 12/05/2022 |
4
| McCamy William C. (President) has filed a Form 4 on Thorne Healthtech, Inc.|
Txns:
| Paid exercise price by delivering 12,175 shares
@ $4.89, valued at
$59.5k
|
|
| 12/05/2022 |
4
| McKenna Thomas P. (COO) has filed a Form 4 on Thorne Healthtech, Inc.|
Txns:
| Paid exercise price by delivering 23,513 shares
@ $4.89, valued at
$115k
|
|
| 12/05/2022 |
4
| JACOBSON PAUL F (CEO) has filed a Form 4 on Thorne Healthtech, Inc.|
Txns:
| Paid exercise price by delivering 45,338 shares
@ $4.89, valued at
$221.7k
|
|
| 11/09/2022 |
8-K
| Quarterly results |
| 08/10/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/09/2022 |
8-K
| Quarterly results |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
|
|
|